| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 264.20B | 257.20B | 243.17B | 227.37B | 225.32B | 197.09B |
| Gross Profit | 41.43B | 39.55B | 32.29B | 30.39B | 29.38B | 26.72B |
| EBITDA | 22.73B | 22.10B | 16.62B | 15.55B | 15.10B | 13.39B |
| Net Income | 12.25B | 11.98B | 7.51B | 6.56B | 6.70B | 5.76B |
Balance Sheet | ||||||
| Total Assets | 214.85B | 233.55B | 231.48B | 221.40B | 216.02B | 201.01B |
| Cash, Cash Equivalents and Short-Term Investments | 52.10B | 50.41B | 45.74B | 46.98B | 51.64B | 51.86B |
| Total Debt | 8.13B | 8.32B | 7.01B | 8.35B | 11.16B | 7.38B |
| Total Liabilities | 69.74B | 85.84B | 89.07B | 86.91B | 86.47B | 77.10B |
| Stockholders Equity | 145.04B | 147.65B | 142.35B | 134.43B | 129.50B | 123.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.08B | 1.71B | 5.83B | 3.88B | -252.00M |
| Operating Cash Flow | 0.00 | 15.08B | 7.80B | 9.69B | 7.93B | 2.65B |
| Investing Cash Flow | 0.00 | -5.80B | 4.32B | -5.30B | -9.81B | -4.62B |
| Financing Cash Flow | 0.00 | -6.84B | -3.37B | -5.45B | -1.46B | -3.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥42.38B | 7.43 | 7.09% | 3.06% | -5.41% | 5.68% | |
76 Outperform | ¥96.56B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
72 Outperform | ¥699.53B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
71 Outperform | ¥184.07B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |